Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase

This study has been completed.
Information provided by:
UConn Health Identifier:
First received: November 27, 2001
Last updated: June 23, 2005
Last verified: November 2001
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2002
  Estimated Primary Completion Date: No date given